Once-weekly Kyprolis with Dexamethasone Approved in US for Relapsed or Refractory Multiple Myeloma
The U.S. Food and Drug Administration has approved…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe U.S. Food and Drug Administration has approved…
Molecular Templates has partnered with Takeda to develop engineered toxin…
The European Medicines Agency has validated Bristol-Myers Squibb’s…
Updated results from a Phase 2b clinical trial continue…
In an effort to inform multiple myeloma patients…
SELLAS Life Sciences’ lead therapy candidate galinpepimut-S (GPS)…